Mountain Crest Acquisition Corp. V is advancing towards a significant merger with CubeBio Holdings Limited, a company based in South Korea. This business combination is poised to reshape the company's future and enhance its position in the surgical and medical instruments industry.

The merger is set to be voted on during a special meeting scheduled for November 11, 2026. Shareholders will have the opportunity to approve the business combination agreement, which includes critical proposals regarding governance and director elections.

Background

Mountain Crest Acquisition Corp. V, incorporated in Delaware, operates as a blank check company. It is focused on entering into a merger or similar business combination with one or more businesses. The company is classified under the SIC code 3841, which pertains to surgical and medical instruments and apparatus. Mountain Crest's shares are traded on the Over-the-Counter (OTC) market under the tickers MCAG, MCAGR, and MCAGU.

What the Filing Says

The definitive proxy statement filed on October 20, 2026, outlines the upcoming special meeting and the proposals to be voted on. The document states, "You are cordially invited to attend the special meeting of the stockholders of Mountain Crest Acquisition Corp. V." The meeting will be conducted virtually, allowing shareholders to participate remotely.

Key proposals include:

  • Business Combination Agreement Proposal: Approval of the merger with CubeBio Holdings Limited.
  • Governance Proposal: Adoption of the new corporate charter for PubCo.
  • Director Proposal: Election of directors for the new entity.
  • PubCo Equity Incentive Plan Proposal: Approval of an equity incentive plan.
  • The Adjournment Proposal: Approval to adjourn the meeting if necessary.

Impact

The outcome of this merger could significantly affect shareholders of Mountain Crest and CubeBio. If approved, the merger will lead to the creation of a new entity, PubCo, which will be listed on Nasdaq under the symbol "KUBE." This transition aims to enhance the company's market presence and operational capabilities in the surgical and medical instruments sector.

What's Next

Following the special meeting, if the shareholders approve the business combination agreement, the merger will proceed. The filing does not specify further steps beyond the vote.